CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 39 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $20,000 | -77.3% | 3,522 | -83.0% | 0.00% | – |
Q2 2018 | $88,000 | -70.5% | 20,694 | -59.3% | 0.00% | – |
Q1 2018 | $298,000 | -11.8% | 50,864 | -30.8% | 0.00% | – |
Q4 2017 | $338,000 | -52.7% | 73,556 | -43.7% | 0.00% | – |
Q3 2017 | $715,000 | +7.8% | 130,558 | +13.1% | 0.00% | – |
Q2 2017 | $663,000 | +325.0% | 115,470 | +324.3% | 0.00% | – |
Q1 2017 | $156,000 | +437.9% | 27,213 | +384.6% | 0.00% | – |
Q4 2016 | $29,000 | -6.5% | 5,616 | -64.6% | 0.00% | – |
Q3 2016 | $31,000 | +3.3% | 15,853 | +6.1% | 0.00% | – |
Q2 2016 | $30,000 | – | 14,939 | +298680.0% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 5 | -100.0% | 0.00% | – |
Q4 2015 | $192,000 | +40.1% | 66,966 | +116.5% | 0.00% | – |
Q3 2015 | $137,000 | +1145.5% | 30,938 | +1306.3% | 0.00% | – |
Q2 2015 | $11,000 | -91.1% | 2,200 | -87.6% | 0.00% | – |
Q4 2014 | $124,000 | +520.0% | 17,800 | +583.0% | 0.00% | – |
Q1 2014 | $20,000 | – | 2,606 | +260500.0% | 0.00% | – |
Q4 2013 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q3 2013 | $75,000 | – | 7,498 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 1,192,080 | $6,282,000 | 2.96% |
COURAGE CAPITAL MANAGEMENT LLC | 100,000 | $527,000 | 0.33% |
Crawford Lake Capital Management, LLC | 69,100 | $364,000 | 0.26% |
Hall Kathryn A. | 31,355 | $166,000 | 0.20% |
ELLINGTON MANAGEMENT GROUP LLC | 29,300 | $154,000 | 0.02% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $116,000 | 0.02% |
Virtu KCG Holdings LLC | 150,357 | $792,000 | 0.02% |
THOMPSON DAVIS & CO., INC. | 2,000 | $11,000 | 0.02% |
Jasper Ridge Partners, L.P. | 47,481 | $250,000 | 0.02% |
AXA S.A. | 479,686 | $2,528,000 | 0.01% |